MOREPENLAB2026-05-20MOREPENLAB2026-05-202026-05-20MOREPENLAB2026-05-202026-05-20RestructuringEntityDomain1MOREPENLAB2026-05-20RestructuringEntityDomain1MOREPENLAB2026-05-202026-05-20RestructuringEntityDomain2MOREPENLAB2026-05-20RestructuringEntityDomain2MOREPENLAB2026-05-202026-05-20RestructuringEntityDomain3MOREPENLAB2026-05-20RestructuringEntityDomain3MOREPENLAB2026-05-202026-05-20RestructuringEntityDomain4MOREPENLAB2026-05-20RestructuringEntityDomain4xbrli:purexbrli:shares500288MOREPEN LABORATORIES LIMITEDMOREPENLABNOTLISTEDINE083A01026NewOther Restructuringtrue2026-05-2018:40:002026-05-20Morepen Laboratories Limited (‘MLL’)Listed Entity (self)10800000.6000010800000.69180000.5100009180000.51Entity/ Persons belonging to promoters & promoter group of MLL OthersCategory of shareholder- Promoter Group6082000.337900006082000.33796082000.337900006082000.3379Mr. Anubhav SuriOthersCategory of shareholder- Promoter Group18000.001000018000.0011638000.09100001638000.091OthersOthersCategory of shareholder- Other Public Shareholders001100000.0611001100000.0611001100000.0611001100000.0611Over the past 15 years, the Medical Devices business of the company has witnessed significant growth and operational progress under the leadership of Mr. Anubhav Suri, Head - Medical Devices Business, who has been instrumental in driving its strategic direction and development. In recognition of his significant contribution, leadership and continued commitment towards the growth and value creation of the Medical Devices business, the company has entered into an agreement for transfer of 1,62,000 equity shares of Morepen Medipath Limited (“MML”), a subsidiary of the company, to Mr. Anubhav Suri, with a view to align his interests with the long-term growth and strategic objectives of MML and to ensure continuity of leadership as the business expands further. The consideration for the transfer has been mutually agreed between the parties. As a result of this transaction, the company's shareholding in MML is reduced to 51%. However, MML will continue to remain a subsidiary of the company and will continue to be consolidated in the company's financial statements.MML will continue to remain a subsidiary of the company and will continue to be consolidated in the company's financial statements.trueMr. Anubhav Suri currently holds 1,800 equity shares (0.10%) in MML. Post this transaction, his shareholding increases to 1,63,800 equity shares (9.10%).